Reshma Rangwala Karyopharm Therapeutics Inc. (KPTI) insider trading activity
Reshma Rangwala is EVP & Chief Medical Officer of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 29,272 shares of KPTI, which is worth approximately $141,969. The most recent transaction as insider was on Mar 04, 2025, when has been sold 3,587 shares (Common Stock) at a price of $6.29 per share, resulting in proceeds of $22,562. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
29.3K
91.46%
3M change
91.63%
12M change
Total Value Held
$141,969
Reshma Rangwala Transaction History
Also insider at
RR
Reshma Rangwala
EVP & Chief Medical Officer
Houston, TX